Regenerate response Nadolol is a drug that belongs to Biopharmaceutics Classification System (BCS) class III, with high solubility and low permeability, has low lipid solubility, and a bioavailability of around 35%.1
A corrigendum2 noted that the authors had used ChatGPT without declaration. The acknowledgements were updated, and the editor undertook “preliminary analyses to confirm the authenticity of the datasets.”
This article was flagged by Guillaume Cabanac on PubPeer.
References
1Kanjarla N, Pasupuleti B, Boggula N, et al. A HPLC-MS/MS method for the determination of Nadolol in rat plasma: Development, validation, and application to pharmacokinetic study. Eur J Mass Spectrom (Chichester). 2023;29(3):170-180. doi:10.1177/14690667231179569
2Corrigendum. Eur J Mass Spectrom (Chichester). 2023;29(4):272-272. doi:10.1177/14690667231195424